---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-167938"
form_type: "8-K"
ticker: "BIIB"
cik: "0000875045"
company_name: "BIOGEN INC."
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:21:31.105948+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Biogen shareholders approve officer exculpation amendment and elect nine directors at annual meeting

## Summary
- Certificate of Amendment filed to allow officer exculpation to extent permitted by Delaware law; approved with 103.1M votes for, 16.3M against.
- All nine director nominees elected with wide margins; Monish Patolawala received 119.1M votes for, highest count.
- Ratification of PwC as independent auditor for FY2024: 123.7M for, 5.3M against.
- Advisory vote on executive compensation passed with 114.4M for, 5.1M against.
- Adoption of 2024 Omnibus Equity Plan and 2024 Employee Stock Purchase Plan both approved.

## SEC filing metadata
- accession: 0001193125-24-167938
- form_type: 8-K
- ticker: BIIB
- cik: 0000875045
- company_name: BIOGEN INC.
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875045/000119312524167938/0001193125-24-167938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875045/000119312524167938/d840763d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-167938
- JSON: https://secwatch.observer/filing/0001193125-24-167938.json
- Plain text: https://secwatch.observer/filing/0001193125-24-167938.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.